Dr. Mamta Jaiswal
Dr. Sushmita Chakraborty
Proteinno MAB Tech Pvt. Ltd. was founded in 2024 by Dr. Mamta Jaiswal (Founder) and Dr. Sushmita Chakraborty (Co-founder). With extensive experience in both academia and industry, they envisioned a biotech start-up dedicated to transforming healthcare through cutting-edge single domain VHH antibody technology.
At Proteinno MAB Tech, we are committed to developing impactful technologies that bridge the gap between advanced research and real-world healthcare challenges. By leveraging the unique properties of Single domain VHH antibodies, we aim to create innovative diagnostics and therapeutics for life-threatening conditions.
Our journey is driven by a passion for scientific discovery and a commitment to addressing critical healthcare challenges.
Single domain VHH antibodies are revolutionary in their compact size, high stability, and exceptional binding specificity. Derived from camelid antibodies, these small yet powerful molecules are ideal for diagnostics, therapeutics, and research applications.
Proteinno MAB Tech Pvt. Ltd. is supported by BIRAC-BIG23 and we are incubated at BioNEST-IIT Guwahati.